PQQ (pyrroloquinoline quinone)
Summary
Small trials co-authored by PQQ makers reported better memory and attention scores at about 20 mg/day for 12 weeks (grade D). EFSA judged 20 mg/day of BioPQQ safe for healthy adults; pregnant and breastfeeding women were outside its assessment. Independent trials and interaction data are lacking.
Key facts
- 21.5 mg/day for 12 weeks improved several Cognitrax domains in older adults (58 completed)[1]
- 20 mg/day for 12 weeks raised prefrontal haemoglobin levels in 20 adults aged 50–70[2]
- EFSA: BioPQQ safe at 20 mg/day for healthy adults except pregnant and breastfeeding women[3]
- 2 graded human outcomes on this page
- October 13, 2026
How it works
ProposedPQQ is a redox cofactor for bacterial enzymes and is studied for effects on mitochondria and brain blood flow; human trials measured cognitive scores and prefrontal oxygenation rather than a confirmed mechanism.[2][3]
What the human research says
Human trials only, one row per outcome. The form column shows what each trial actually tested. Grades follow our evidence-grading policy.
| Outcome | Effect | Grade | Best evidence | PMID |
|---|---|---|---|---|
| Memory, attention and cognitive flexibility | Improved | Grade D | RCT · n = 58 · 2022 Japanese adults (mean age about 71) who felt more forgetful (58 of 64 completed) Form: PQQ disodium salt (mnemoPQQ) vs placebo · Dose: 21.5 mg/day · Duration: 12 weeks Composite memory, verbal memory, reaction time, complex attention, cognitive flexibility, executive function and motor speed improved vs placebo; no adverse events. | 34415830 (opens PubMed)Source [1] |
| Prefrontal blood flow and oxygenation | Improved | Grade D | RCT · n = 20 · 2016 Healthy adults aged 50–70 Form: BioPQQ vs placebo · Dose: 20 mg/day · Duration: 12 weeks Baseline haemoglobin and total haemoglobin in the right prefrontal cortex rose significantly after PQQ. | 27526146 (opens PubMed)Source [2] |
Forms
Studied doses
Doses studied in human trials ranged from 20 mg/day of BioPQQ for 12 weeks to 21.5 mg/day of PQQ disodium salt for 12 weeks.[1][2]
Interactions
Published interactions only: each row cites a source. No row means none was found in our sources, not that a combination is safe.
None found in our sources.
Who should be careful
- Pregnancy and breastfeeding
- EFSA assessed PQQ only for healthy adults excluding pregnant and lactating women.[3]
- Children
- The EU safety assessment covers adults only.[3]
Talk to your pharmacist or clinician before starting a supplement, especially if you take prescription medicines.
Frequently asked questions
Does PQQ improve memory?
Small 12-week trials co-authored by PQQ makers reported better memory and attention scores; independent trials are lacking.[1][2]
Is PQQ safe?
EFSA judged 20 mg/day of BioPQQ safe for healthy adults, excluding pregnant and breastfeeding women.[3]
Does PQQ interact with medicines?
No interaction studies were found; check with a pharmacist if you take regular medicines.[3]
Sources
- [1]Effect of Dietary Pyrroloquinoline Quinone Disodium Salt on Cognitive Function in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study.. J Am Nutr Assoc, 2022. RCT
- [2]Effects of Antioxidant Supplements (BioPQQ™) on Cerebral Blood Flow and Oxygen Metabolism in the Prefrontal Cortex.. Adv Exp Med Biol, 2016. RCT
- [3]Safety of pyrroloquinoline quinone disodium salt as a novel food pursuant to Regulation (EC) No 258/97.. EFSA J, 2017. safety-communication
What changed
- Editorial evidence re-review: maker involvement now says co-authored (author affiliations checked on PubMed); EFSA scope worded as its exclusion of pregnant and lactating women rather than a finding of harm.
- Second-pass self-review: every PMID re-checked against NCBI esummary (title, year, no retraction or expression-of-concern flag), every dose, n and duration re-read against the PubMed abstract or PMC full text, grades held conservative, and interactions limited to what a cited source supports.
- First draft. Source titles and years taken from NCBI E-utilities esummary; abstracts read for every evidence row.
